Pluristem Therapeutics Inc (NASDAQ:PSTI)
| 3.05 Data as of May 17 |  0.00 / 0.00%Today’s Change | 2.26 Today|||52-Week Range 5.00 | -4.39% Year-to-Date |
Latest PSTI News | Press Releases
No recent news for Pluristem Therapeutics Inc.
Today’s Trading
| Previous close | 3.05 |
| Today’s open | 3.05 |
| Day’s range | 3.00 - 3.06 |
| Volume | 116,712 |
| Average volume (3 months) | 185,737 |
| Market cap | $178.8M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +2.86% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 147.59 |
| Price/Book | 3.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NSPHNanosphere Inc | 0.00 | 0.00% |
| SIGASIGA Technologies In... | -0.02 | -0.56% |
| VSTMVerastem Inc | -0.25 | -2.65% |
| PACBPacific Biosciences ... | -0.05 | -2.02% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | May 29, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $716.0K |
| Annual profit (last year) | -$14.8M |
| Net profit margin | -2,066.20% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Zami Aberman |
Vice President- Operations Arie Lahav, MBA |
Corporate headquarters Haifa, -- |
Forecasts
